<PAGE>
POST-EFFECTIVE AMENDMENT NO. 1
As filed with the Securities and Exchange Commission on October 25, 2000
Registration No. 333-37866
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
Post-Effective Amendment No. 1
to
Form S-1
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
__________________________
Curon Medical, Inc.
(Exact name of registrant as specified in its charter)
Delaware 735 Palomar Avenue 77-0470324
(State or other jurisdiction Sunnyvale, California 94085 (I.R.S. Employer
of incorporation or (408) 733-9910 Identification No.)
organization)
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
__________________________
John W. Morgan
Chief Executive Officer
CURON MEDICAL, INC.
735 Palomar Avenue
Sunnyvale, California 94085
(408) 733-9910
(Name, address, including zip code, and telephone number, including
area code, of agent for service)
__________________________
Copies to:
J. Casey McGlynn, Esq. Donald J. Murray, Esq.
David J. Saul, Esq. Dewey Ballantine LLP
Wilson Sonsini Goodrich & Rosati 1301 Avenue of the Americas
Professional Corporation New York, New York 10019
650 Page Mill Road (212) 259-8000
Palo Alto, California 94304
(650) 493-9300
__________________________
The registrant hereby requests that this Post-Effective Amendment No. 1
become effective as soon as practicable pursuant to Section 8(c) of the
Securities Act of 1933.
<PAGE>
On May 25, 2000, Curon Medical, Inc., a Delaware corporation ("Curon
Medical"), filed Registration Statement No. 333-37866 on Form S-1 (the
"Registration Statement") to register 5,750,000 shares (the "Shares") of common
stock, $.001 par value per share, of Curon Medical (the "Common Stock").
On October 21, 2000, the Registration Statement became effective. Since
the effective date, UBS Warburg LLC, the lead underwriter, has exercised its
over-allotment option for 475,000 of the 750,000 allotted shares. Accordingly,
Curon Medical hereby deregisters a total of 275,000 shares of Common Stock,
comprised of the Shares not sold by Curon Medical during the effective period.
-2-
<PAGE>
SIGNATURES AND POWER OF ATTORNEY
Pursuant to the requirements of the Securities Act of 1933, the registrant has
duly caused this Post-Effective Amendment No. 1 to the Registration Statement to
be signed on its behalf by the undersigned, thereunto duly authorized, in the
city of Sunnyvale, California, on the 25th day of October, 2000.
Curon Medical, Inc.
Date: October 25, 2000 By: /s/ John W. Morgan*
--------------------------------------
John W. Morgan
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this Post-
Effective Amendment No. 1 to the Registration Statement has been signed below by
the following persons in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
<S> <C> <C>
Signature Capacity Date
--------- -------- ----
John W. Morgan* President and Chief Executive October 25, 2000
-------------------------- Officer and Director (Principal
John W. Morgan Executive Officer)
/s/ Alistair F. McLaren Chief Financial Officer and Vice October 25, 2000
--------------------------- President of Finance and
Alistair F. McLaren Administration (Principal
Financial Officer)
Michael Berman* Director October 25, 2000
----------------------------
Michael Berman
Fred Brown* Director October 25, 2000
----------------------------
Fred Brown
David I. Fann* Director October 25, 2000
----------------------------
David I. Fann
Alan L. Kaganov* Director October 25, 2000
----------------------------
Alan L. Kaganov
Robert F. Kuhling, Jr.* Director October 25, 2000
----------------------------
Robert F. Kuhling, Jr.
</TABLE>
*By: /s/ Alistair F. McLaren
------------------------------
Alistair F. McLaren
Attorney-in-fact
-3-
